Smith & Nephew Aktie
13,49EUR | -0,11EUR | -0,81% |
WKN: 502816 / ISIN: GB0009223206
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 17 914 | 18 369 | 20 122 | 19 551 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,20 | 0,21 | 0,21 | 0,23 | 0,00 |
Bilanz (in Mio. GBP) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 3 412 | 3 266 | 3 206 | 3 161 | 3 530 |
Summe Anlagevermögen | 4 644 | 4 796 | 5 079 | 4 673 | 4 737 |
Summe Aktiva | 8 056 | 8 062 | 8 285 | 7 834 | 8 267 |
Bilanz (in Mio. GBP) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 4 194 | 3 951 | 3 913 | 3 742 | 4 063 |
Summe Eigenkapital | 3 862 | 4 111 | 4 372 | 4 092 | 4 204 |
Summe Passiva | 8 056 | 8 062 | 8 285 | 7 834 | 8 267 |
Adresse
Croxley Park, WD18 8YE Watford | |
Telefon | +44 (1923) 477-100 |
Internet | http://www.smith-nephew.com |
Management
Alison Parkes
Chief Compliance Officer |
Andrew John Swift
Head-Investor Relations |
Angela Susan Risley
Senior Independent Director |
Bradley J. Cannon
President-Orthopedics, Sports Medicine & ENT |
Deepak S Nath
Chief Executive Officer & Director |
Elga Lohler
Chief Human Resources Officer |
Helen Barraclough
Secretary & Group General Counsel |
Jeremy Kim Maiden
Independent Non-Executive Director |
Jo C. Hallas
Independent Non-Executive Director |
John C. Ma
Independent Non-Executive Director |
John Terence Rogers
Chief Financial Officer & Director |
Katarzyna Mazur-Hofsaess
Independent Non-Executive Director |
Marc E. Owen
Senior Independent Director |
Mizanu Kebede
Chief Quality & Regulatory Affairs Officer |
Paul Connolly
President-Global Operations |
Philip G. Cowdy
Chief Corporate Development Officer |
Robert White
Independent Non-Executive Director |
Rupert Christopher Soames
Chairman |
Simon Jonathan Lowth
Independent Non-Executive Director |
Sybella Stanley
Independent Non-Executive Director |
Vasant Padmanabhan
President-Research & Development |